EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults
Portfolio Pulse from Vandana Singh
Akili Inc (NASDAQ:AKLI) has released EndeavorOTC, a mobile video game treatment for adults with ADHD, which is clinically proven to improve attention and focus. The game is built on the same technology as EndeavorRx, the FDA-authorized video game treatment for children with ADHD. EndeavorOTC is now available without a prescription for adults 18 years and older nationwide.
June 08, 2023 | 3:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Akili Inc's EndeavorOTC, a mobile video game treatment for adults with ADHD, is now available without a prescription for adults 18 years and older nationwide. The game is built on the same technology as EndeavorRx, the FDA-authorized video game treatment for children with ADHD.
The release of EndeavorOTC is a significant milestone for Akili Inc as it expands its product offerings to a wider audience. The game's clinical effectiveness in improving attention and focus in adults with ADHD, combined with its availability without a prescription, could lead to increased adoption and revenue for the company. This positive news is likely to have a short-term positive impact on AKLI's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100